AC Immune (ACIU) EBT (2015 - 2026)
AC Immune's (ACIU) quarterly EBT came in at -$18.9 million in Q1 2026, up 10.7% year-on-year from -$17.1 million in Q1 2025, and down 5.1% on a QoQ basis from -$18.0 million in Q4 2025.
AC Immune (ACIU) EBT (2015 - 2026) Analysis & Trends
AC Immune (ACIU) has 12 years of EBT data on file, last reported at -$18.9 million in Q1 2026.
- On a quarterly basis, EBT rose 10.7% year-over-year to -$18.9 million in Q1 2026; TTM through Mar 2026 was -$82.3 million, a 41.87% decrease from a year earlier, with the FY2025 full-year figure at -$85.0 million, down 46.2% from the prior year.
- EBT for Q1 2026 stood at -$18.9 million, down from -$18.0 million in the prior quarter.
- Over the last five years, EBT for ACIU reached as high as $6.4 million in Q3 2024 and fell as low as -$25.6 million in Q2 2025.
- Historically, EBT has averaged -$17.4 million across 5 years, with a median of -$18.9 million in 2023.
- Across the five-year window, EBT surged 137.06% in 2024 and sank 412.11% in 2025, its largest moves.
- Year by year, EBT stood at -$19.5 million in 2022, then soared by 72.52% to -$5.3 million in 2023, then slumped by 237.18% to -$18.0 million in 2024, then gained by 0.26% to -$18.0 million in 2025, then retreated by 5.1% to -$18.9 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$18.9 million in Q1 2026, -$18.0 million in Q4 2025, and -$19.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | AC Immune | 222.66 Mn | 222.66 Mn | - | -18.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.90 Mn |
| Dec 31, 2025 | -17.98 Mn |
| Sep 30, 2025 | -19.82 Mn |
| Jun 30, 2025 | -25.59 Mn |
| Mar 31, 2025 | -21.17 Mn |
| Dec 31, 2024 | -18.03 Mn |
| Sep 30, 2024 | 6.35 Mn |
| Jun 30, 2024 | -25.17 Mn |
| Mar 31, 2024 | -20.46 Mn |
| Dec 31, 2023 | -5.35 Mn |
| Sep 30, 2023 | -17.14 Mn |
| Jun 30, 2023 | -18.72 Mn |
| Mar 31, 2023 | -18.93 Mn |
| Dec 31, 2022 | -19.46 Mn |
| Sep 30, 2022 | -13.99 Mn |
| Jun 30, 2022 | -20.39 Mn |
| Mar 31, 2022 | -20.40 Mn |
| Dec 31, 2021 | -23.07 Mn |
| Sep 30, 2021 | -17.34 Mn |
| Jun 30, 2021 | -20.91 Mn |